Training on Optimization of Behavioral and Biobehavioral Interventions
Topic: Optimization of Behavioral and Biobehavioral Interventions
SAVE THE DATE: May 13-17, 2019
Venue: Bethesda, MD
Sponsors: Office of Behavioral and Social Science Research (OBSSR) and National Institute on Drug Abuse (NIDA)
This webpage describes the training that took place in May 2018. Visit The Methodology Center website in fall 2018 for more information about the 2019 training.
The goal of this five-day training is to help attendees gain the skills they need to use the multiphase optimization strategy (MOST) to optimize behavioral and biobehavioral interventions. Optimization of fixed (traditional) and adaptive interventions will be covered.
Time will be spent in lecture, discussion, and demonstration of software. The team of instructors and presenters includes both methodologists and intervention scientists. One day will include a panel discussion of scientists who have obtained funding for optimization from NIH and who have conducted optimization trials.
One year of graduate-level statistics, which should include training through multiple regression, is a prerequisite. Some training in the randomized controlled trial (RCT) and experience with development of behavioral or biobehavioral interventions are also needed.
Topics to be covered:
- multiphase optimization strategy (MOST)
- fixed and adaptive interventions
- Design of optimization trials, including
- factorial and fractional factorial designs
- sequential, multiple assignment, randomized trial (SMART)
- practical aspects of conducting optimization trials in varied field settings
- obtaining funding for optimization projects
The application period is from December 4, 2017 to 11:59 pm, January 26, 2018.
Enrollment is limited so that we can maintain an informal atmosphere and encourage interaction. Priority will be given to individuals who have the appropriate background and who are likely to apply skills gained in the training to their own work.
The registration fee of $400 for the five-day training covers all instruction and program materials including a copy of Dr. Collins' new book, Optimization of Behavioral, Biobehavioral, and Biomedical Interventions: The Multiphase Optimization Strategy (MOST). A waiver of the registration fee is available for a limited number of individuals to maximize minority representation and support early-career scientists. Lodging will be provided for all attendees with U.S. citizenship or permanent resident status who stay at the Bethesda Marriott North. A limited amount of additional travel support will be awarded on the basis of need.
To apply to attend the training, please fill out the application. Applications must be submitted by January 26, 2018. Applicants will be notified about decisions by March 1, 2018.
Once accepted, participants will be emailed instructions about how to register.
Please contact Kate Guastaferro (firstname.lastname@example.org) for more information.
Review our refund, access, and cancellation policies.
Instructors will deliver the primary portion of the curriculum. Presenters are intervention scientists who will share their experience with applications of the methods covered in the curriculum.
Daniel Almirall, Ph.D. (instructor)
Research Associate Professor in the Institute of Social Research, University of Michigan
Investigator, The Methodology Center
Daniel Almirall is interested in methods and study designs used to form adaptive interventions (AIs). AIs can be used to inform individualized treatment guidelines for the on-going management of chronic illnesses or disorders such as drug abuse, depression, autism, obesity, or HIV/AIDS. Dr. Almirall works on methods for the design and analysis of sequential multiple assignment randomized trials (SMARTs) which can used to build and optimize AIs. He is also interested in the development of methods for causal inference in which treatments, covariates, and outcomes are all time-varying.
Linda M. Collins, Ph.D. (instructor)
Director, The Methodology Center
Distinguished Professor of Health and Human Development and Professor of Statistics, Penn State
Linda M. Collins is the primary developer of the multiphase optimization strategy (MOST), a comprehensive, principled, engineering-inspired framework for developing, optimizing, and evaluating multicomponent behavioral, biobehavioral and biomedical interventions. She collaborates with intervention scientists (including presenters Dr. Gwadz, Dr. Kugler, and Dr. Piper) to develop optimized interventions in a broad range of fields including tobacco cessation, HIV-treatment services, and prevention of sexually transmitted infections.
Kate Guastaferro, Ph.D. (instructor)
Assistant Research Professor, The Methodology Center, Penn State
Kate Guastaferro researches the development, optimization, evaluation, and dissemination of behavioral interventions using the multiphase optimization strategy (MOST). Substantively her focus is in the prevention of child maltreatment, with an eye toward co-occurring risk factors such as parental substance use and mental health.
Marya Gwadz, Ph.D. (presenter)
Director of the Transdisciplinary Research Methods Core in the Center for Drug Use and HIV Research (CDUHR)
Senior Research Scientist, NYU Rory Meyers College of Nursing
Marya Gwadz is a licensed clinical psychologist and Senior Research Scientist at the New York University Rory Meyers College of Nursing. She serves as the Director of the Transdisciplinary Research Methods Core in the NIDA-funded Center for Drug Use and HIV Research, in which she has played a leadership role since 2005. The main focus of her research is the development and evaluation of potent, innovative, multi-level culturally salient interventions to address racial/ethnic, socioeconomic, and gender inequalities in health, with an emphasis on HIV and substance use.
Megan Piper, Ph.D. (presenter)
Assistant Professor in the University of Wisconsin Department of Medicine
Associate Director of Research at UW-Center for Tobacco Research and Intervention
Dr. Piper’s research focuses on understanding and treating tobacco dependence, with an additional interest in different populations of smokers who have more difficulty quitting, such as women and smokers with mental illness. She has published more than 100 peer-reviewed papers, has served on various NIH study sections, has served as a Co-Investigator on numerous grants, and is currently a Project Director on a National Cancer Institute P01 focused on developing optimized smoking cessation treatments in primary care and a PI on a National Cancer Institute R01 on a longitudinal study of smokers and dual users (e-cigarette and combustible cigarette users).
David Wyrick, Ph.D. (presenter)
Associate Professor of Public Health Education, University of North Carolina at Greensboro
Director, Institute to Promote Athlete Health & Wellness
Dr. Wyrick is an associate professor of public health education at the University of North Carolina at Greensboro (UNCG) where he founded and directs the Institute to Promote Athlete Health & Wellness. Dr. Wyrick has extensive experience in prevention research, evaluation, and intervention development. He has completed a study that implemented MOST to optimize myPlaybook, an alcohol and other drug prevention program for collegiate student-athletes. myPlaybook has been used by more than 400 colleges nationally. He is currently collaborating with Drs. Collins on another MOST project to optimize itMatters, an online intervention to reduce sexually transmitted diseases on college campuses.
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
North Bethesda, MD 20852
Funding for this conference was made possible by P50 DA039838 from the National Institute on Drug Abuse (NIDA) and support from the Office of Behavioral and Social Science Research (OBSSR). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.